These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

130 related items for PubMed ID: 16794466

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. [Physiological and pathological cardiac hypertrophy].
    Magnani B.
    Ital Heart J; 2000 Jun; 1 Suppl 2():42-9. PubMed ID: 10905128
    [Abstract] [Full Text] [Related]

  • 27. Prognostic importance of hemoglobin in hypertensive patients with electrocardiographic left ventricular hypertrophy: the Losartan Intervention For End point reduction in hypertension (LIFE) study.
    Olsen MH, Wachtell K, Beevers G, Dahlöf B, Devereux RB, de Faire U, Fyhrquist F, Ibsen H, Kjeldsen SE, Lederballe-Pedersen O, Lindholm LH, Narayan P, Nieminen MS, Omvik P, Oparil S, Wedel H.
    Am Heart J; 2009 Jan; 157(1):177-84. PubMed ID: 19081416
    [Abstract] [Full Text] [Related]

  • 28. [Can regression of left ventricular hypertrophy be proposed as a substitute criterion in trials of morbidity/mortality in hypertension?].
    Gosse P, Herpin D.
    Arch Mal Coeur Vaiss; 2000 Nov; 93(11 Suppl):1435-40. PubMed ID: 11190293
    [Abstract] [Full Text] [Related]

  • 29. Diagnosis and characterization of left ventricular hypertrophy by computerized acoustic cardiography, brain natriuretic peptide, and electrocardiography.
    Rogers RK, Collins SP, Kontos MC, Zuber M, Arand P, Michaels AD.
    J Electrocardiol; 2008 Nov; 41(6):518-25. PubMed ID: 18804784
    [Abstract] [Full Text] [Related]

  • 30. Effects of losartan compared with atenolol on lipids in patients with hypertension and left ventricular hypertrophy: the Losartan Intervention For Endpoint reduction in hypertension study.
    Olsen MH, Wachtell K, Beevers G, Dahlöf B, de Simone G, Devereux RB, de Faire U, Fyhrquist F, Ibsen H, Kjeldsen SE, Lederballe-Pedersen O, Lindholm LH, Lyle PA, Nieminen MS, Omvik P, Oparil S, Wedel H.
    J Hypertens; 2009 Mar; 27(3):567-74. PubMed ID: 19262226
    [Abstract] [Full Text] [Related]

  • 31. Incidence of atrial fibrillation in relation to changing heart rate over time in hypertensive patients: the LIFE study.
    Okin PM, Wachtell K, Kjeldsen SE, Julius S, Lindholm LH, Dahlöf B, Hille DA, Nieminen MS, Edelman JM, Devereux RB.
    Circ Arrhythm Electrophysiol; 2008 Dec; 1(5):337-43. PubMed ID: 19808428
    [Abstract] [Full Text] [Related]

  • 32. Left atrial systolic force in hypertensive patients with left ventricular hypertrophy: the LIFE study.
    Chinali M, de Simone G, Wachtell K, Gerdts E, Gardin JM, Boman K, Nieminen MS, Papademetriou V, Dahlöf B, Devereux RB.
    J Hypertens; 2008 Jul; 26(7):1472-6. PubMed ID: 18551025
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Blood pressure reduction and antihypertensive medication use in the losartan intervention for endpoint reduction in hypertension (LIFE) study in patients with hypertension and left ventricular hypertrophy.
    Devereux RB, de Faire U, Fyhrquist F, Harris KE, Ibsen H, Kjeldsen SE, Lederballe-Pedersen O, Lindholm LH, Nieminen MS, Omvik P, Oparil S, Wedel H, Hille DA, Dahlöf B.
    Curr Med Res Opin; 2007 Feb; 23(2):259-70. PubMed ID: 17288679
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. The impact of left ventricular hypertrophy on early and long-term survival after coronary artery bypass grafting.
    Toumpoulis IK, Chamogeorgakis TP, Angouras DC, Swistel DG, Anagnostopoulos CE, Rokkas CK.
    Int J Cardiol; 2009 Jun 12; 135(1):36-42. PubMed ID: 18579225
    [Abstract] [Full Text] [Related]

  • 39. Prevalence and clinical correlates of right ventricular hypertrophy in essential hypertension.
    Cuspidi C, Negri F, Giudici V, Valerio C, Meani S, Sala C, Esposito A, Masaidi M, Zanchetti A, Mancia G.
    J Hypertens; 2009 Apr 12; 27(4):854-60. PubMed ID: 19516183
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.